Pfizer on Tuesday forecast 2026 profit below Wall Street estimates as it expects a steep drop in sales of its COVID products ...
Wall Street stocks clocked another down day on Monday, with considerable rotation of stock sectors marking the year-end and ...
For more than two years it had the entirety of the market for weight-loss drugs to itself. By 2023 sales of Wegovy had ...
A federal judicial panel said Monday it would centralize a growing number of lawsuits against Novo Nordisk and Eli Lilly ...
The U.S. Food and Drug Administration said on Monday it has granted a national priority voucher to Johnson & Johnson's blood ...
Health and Me on MSN
Ozempic launches in India at Rs 2,200 for starter dose: All you need to know
Novo Nordisk has launched its popular diabetes drug Ozempic in India, with the weekly 0.25 mg starter dose priced at ₹2,200.
Novo Nordisk has officially launched Ozempic for diabetes treatment in India. Let's learn more about how this injection works ...
Investor's Business Daily on MSN
Eli Lilly Rises, Again, After EMA Groups Recommends Mounjaro For Children As Young As 10
On Friday, an EMA committee recommended extending the use of Eli Lilly's type 2 diabetes drug, Mounjaro, to children as young ...
Leaders at the U.S. Food and Drug Administration have pressed internally for reviewers to speed up their evaluation of Eli ...
Novo Nordisk launched Ozempic in India on Friday—and the weight-loss drug will sell at a massive discount there, compared ...
Leaders at the U.S. Food and Drug Administration have pressed internally for reviewers to speed up their evaluation of Eli Lilly's experimental weight‑loss pill, after the company pushed for a faster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback